Evidence map›Paper›PMID 38759023›Full record

ArticleJournal of neuromuscular diseases2024

Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy.

Dilek Cavusoglu, Beril Talim, Gazanfer Ekinci, Haluk Topaloglu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuromuscular diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dilek CavusogluDepartment of Pediatric Neurology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyon, Turkey.
Beril TalimDepartment of Pediatrics, Pathology Unit, Hacettepe University, Ankara, Turkey.
Gazanfer EkinciDepartment of Radiology, Yeditepe University School of Medicine, Istanbul, Turkey.
Haluk TopalogluDepartment of Pediatrics, Yeditepe University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, anti-HMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.

Indexed as

Muscular DiseasesAutoantibodiesChildFemaleFollow-Up StudiesHumansHydroxymethylglutaryl CoA ReductasesImmunoglobulins, IntravenousAutoantibodiesHMGCR protein, humanHydroxymethylglutaryl CoA ReductasesImmunoglobulins, IntravenousAnti-HMGCR myopathychildrenmuscle weaknesstreatment

Identifiers

PMID38759023
PMCPMC11307026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.